A newly developed technology called “augmented whole-body scanning via magnifying PET” (AWSM-PET) has been shown to enhance the image resolution and system sensitivity of clinical whole-body PET/CT imaging.

June 24, 2023 — A newly developed technology called “augmented whole-body scanning via magnifying PET” (AWSM-PET) has been shown to enhance the image resolution and system sensitivity of clinical whole-body PET/CT imaging. The cost-effective technology, presented at the 2023 Society of Nuclear Medicine and Molecular Imaging Annual Meeting, uses high resolution add-on detectors that simultaneously scan a patient during a standard whole-body PET scan.

“Whole-body PET/CT imaging is broadly used for cancer staging and restaging and to evaluate patients’ response to treatment interventions; however, its diagnostic accuracy is compromised when the lesions are very small or exhibit weak signals,” said Yuan-Chuan Tai, PhD, associate professor of radiology at Washington University in St. Louis, Missouri. “Our novel AWSM-PET prototype helps to tackle two of the key limitations in whole-body PET imaging: image resolution and overall system sensitivity.”

The AWSM-PET technology utilizes two high-resolution PET detectors that are placed outside of a scanner’s axial imaging field of view as an “outsert” device. The device simultaneously acquires high-resolution PET data as a patient undergoes whole-body PET, and customized firmware and software encode and jointly reconstruct the data. In the study, a cylindrical phantom with lesions ranging from 1.96 mm to 7.6 mm in diameter was imaged to test the AWSM-PET technology.  

Results revealed a clear improvement in image resolution with the AWSM-PET device. The firmware and software were also validated to confirm the functionality of the prototype device.

“The additional high-resolution data from the AWSM-PET device can enhance the overall image resolution and reduce statistical noise,” noted Tai. “The potential improvement in diagnostic accuracy of clinical whole-body PET/CT may benefit cancer patients.”

A pilot human imaging trial is scheduled to start in the summer of 2023 at the Washington University School of Medicine in St. Louis, Missouri. The trial will compare the diagnostic accuracy of the AWSM-PET technology against the standard FDG whole-body PET/CT. 

For more information: www.snmmi.org

Find more SNMMI23 conference coverage here


Related Content

News | Quality Assurance (QA)

November 25, 2023 — Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry ...

Time November 25, 2023
arrow
News | PET-CT

November 22, 2023 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of the Biograph ...

Time November 22, 2023
arrow
News | Artificial Intelligence

November 21, 2023 — Heuron, a medical AI (artificial intelligence) imaging software solution company, under the ...

Time November 21, 2023
arrow
News | Information Technology

November 21, 2023 — GE HealthCare has received U.S. FDA 510(k) Clearance for the new version of Digital Expert Access ...

Time November 21, 2023
arrow
News | PET Imaging

November 8, 2023 — In a small study, researchers at the National Institutes of Health have found that positron emission ...

Time November 08, 2023
arrow
News | Linear Accelerators

October 25, 2023 — A new order for several Elekta Harmony linear accelerators (linacs) in Ukraine will complement the ...

Time October 25, 2023
arrow
News | Proton Therapy

October 23, 2023 — IBA, a world leader in particle accelerator technology and the world’s leading provider of proton ...

Time October 23, 2023
arrow
News | Radiopharmaceuticals and Tracers

October 20, 2023 — Meilleur Technologies, Inc. announced a research collaboration agreement with the Alzheimer’s Disease ...

Time October 20, 2023
arrow
News | Radiation Therapy

October 19, 2023 — The lung is one of the tissues most sensitive to radiation in the human body. People exposed to high ...

Time October 19, 2023
arrow
News | Radiopharmaceuticals and Tracers

October 18, 2023 —ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Canadian ...

Time October 18, 2023
arrow
Subscribe Now